SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

RBC Capital Maintains Outperform on Sage Therapeutics, Raises Price Target to $72

RBC Capital maintains Sage Therapeutics (NASDAQ:SAGE) with a Outperform and raises the price target from $71 to $72.

Benzinga · 05/08/2020 13:39

RBC Capital maintains Sage Therapeutics (NASDAQ:SAGE) with a Outperform and raises the price target from $71 to $72.